{"filing":{"accession_number":"0001493152-26-041253","cik":"0001725430","ticker":"INBS","company_name":"INTELLIGENT BIO SOLUTIONS INC.","form":"8-K","filing_date":"2026-09-02","report_date":"2026-08-31","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315226041253/form8-k.htm"},"events":[{"id":31381,"run_id":28787,"accession_number":"0001493152-26-041253","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a private placement of 2,036,659 shares of common stock (or pre-funded warrants in lieu thereof) plus Series N-1 and Series N-2 warrants to purchase an aggregate of 4,073,318 additional shares, for gross proceeds of approximately $5.0 million. This is an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, structured as a PIPE-like transaction with multiple warrant tranches. The dilutive nature is evident from the warrant exercise prices ($2.33 per share) and the callable Series N-1 warrants tied to FDA 510(k) clearance, indicating a capital raise by a small-cap medical device company (Nasdaq: INBS).","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-02","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":34237,"accession_number":"0001493152-26-041253","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a private placement of 2,036,659 shares of common stock (or pre-funded warrants in lieu thereof) plus Series N-1 and Series N-2 warrants to purchase an aggregate of 4,073,318 additional shares, for gross proceeds of approximately $5.0 million. This is an unregistered sale of equity securities under Section 4(a)(2) and Regulation D, structured as a PIPE-like transaction with multiple warrant tranches. The dilutive nature is evident from the warrant exercise prices ($2.33 per share) and the callable Series N-1 warrants tied to FDA 510(k) clearance, indicating a capital raise by a small-cap medical device company (Nasdaq: INBS).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T21:03:30.476833+00:00","company_name":"INTELLIGENT BIO SOLUTIONS INC.","ticker":"INBS","filing_date":"2026-09-02"}]}